Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZBH
#616
Zimmer Biomet Holdings, Inc. Common Stock
99.4
8
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.87%
Monthly Change
+4.38%
6 month change
+2.70%
Year Change
-3.88%
Previous Close
101.3
8
Open
100.2
9
Low
99.2
1
High
100.3
2
Volume
889
Markets
US Stock Market
Healthcare
Medical Devices
ZBH
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
207.86 M
209.18 M
208.98 M
205.08 M
199.06 M
195.65 M
190.74 M
Valuation ratios
Enterprise value
39.36 B
33.17 B
31.93 B
30.25 B
26.71 B
23.94 B
26.02 B
Price to earnings ratio
-229.99
66.51
115.71
24.88
23.84
25.33
24.11
Price to sales ratio
4.41
3.32
3.77
3.35
2.73
2.25
2.37
Price to cash flow ratio
26.48
17.83
18.75
16.09
14.36
10.53
11.2
Price to book ratio
2.62
2.11
2.23
2.04
1.73
1.41
0.38
Enterprise value to EBITDA ratio
53.7
20.24
21.9
14.92
12.94
12.61
12.85
Profitability ratios
Return on assets %
-0.01
0.02
0.01
0.05
0.04
0.03
0.01
Return on equity %
-0.01
0.03
0.02
0.08
0.07
0.06
0.02
Return on invested capital %
-0.78
13.54
9.65
24.67
22.48
17.45
4.71
Gross margin %
68.76
69.31
70.19
71.03
70.63
68.59
69.8
Operating margin %
-1.29
10.23
10.28
17.76
17.23
13.83
15.5
EBITDA margin %
10.76
21.49
21.52
28.2
27.67
23.92
24.9
Net margin %
-2.04
5.26
3.42
14.24
12.11
8.88
9.42
Liquidity ratios
Quick ratio
1.03
0.72
0.97
0.78
0.99
1.1
0.94
Current ratio
1.99
1.41
1.88
1.61
1.91
1.98
1.69
Inventory turnover
0.88
0.97
0.89
0.92
0.95
1.09
0.28
Asset turnover
0.28
0.32
0.3
0.34
0.35
0.34
0.09
Solvency ratios
Debt to assets ratio
0.31
0.23
0.24
0.23
0.25
0.3
0.33
Debt to equity ratio
0.63
0.43
0.43
0.39
0.43
0.55
0.59
Long term debt to total assets ratio
0.01
0.04
0.04
0.04
0.04
0.04
0.04
Long term debt to total equity ratio
0.03
0.08
0.07
0.07
0.07
0.07
0.07
Per share metrics
Operating cash flow per share
5.82
7.13
6.11
7.54
7.35
8.54
8.87
EBIT per share
0.6
4.7
4.09
7.05
7.37
4.05
4.67
EBITDA per share
3.54
7.79
6.93
9.67
10.12
9.56
10.31
Total debt per share
36.84
25.97
24.5
23.21
26.2
34.89
38.79
Cash per share
3.87
2.27
1.79
1.98
2.58
2.98
2.13
Net current asset value per share
24.56
23.22
21.05
21.98
22.91
25.77
26.44
Tangible book value per share
58.91
60.17
57.16
59.52
61.15
-9.9
-9.11
Working capital per share
12.2
6.74
9.84
8.36
10.89
12.76
10.8
Book value per share
58.91
60.17
57.16
59.52
61.15
63.9
65.48
News
Stryker: The Sell-Off Creates A Better Entry Point, But Q2 Wasn’t Perfect (NYSE:SYK)
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man’s Land (NYSE:ENOV)
Disappointing Ortho Performance Continues To Hold Smith & Nephew Back (Downgrade) (SNN)
Is ISRG's Software Strategy Becoming as Important as Its Robots?
Stryker Corporation: Hold For Quality, Wait For The Dip (NYSE:SYK)
SYK Stock Gains 3.8% Since March-End: What's Driving the Uptrend?
Are Wall Street Analysts Bullish on Zimmer Biomet Stock?
Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Is SYK Worth Buying as Growth Improves but Execution Risks Persist?
Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Intuitive Surgical: Priced For Precision (NASDAQ:ISRG)